BIO Europe 2018

#BIOEurope: ‘Deal making is off the charts and the IPO window is open’

By Flora Southey contact

- Last updated on GMT

(Image: Getty/© Allard Schager)
(Image: Getty/© Allard Schager)

Related tags: Europe, Denmark, Partnership

Denmark played host to its first BIO Europe this week, welcoming 4,500 attendees from across the globe – including growing numbers from China and South Korea.

It is a good time to be in biotech, EBD Group and KNect365 Life Sciences managing director, Anna Chrisman, told delegates on Monday. “Deal making is off the charts and the IPO window is open – and that seems to be true in the US, Europe and Asia alike.

“The pace of innovation and the delivery of value to patients continues to accelerate and drug approvals are at an all-time high,” ​Chrisman added.

Biopharma-Reporter joined the biotech world in Copenhagen this week, to cover partnering trends, Chinese investment opportunities, and the ‘make or buy’ dilemma in the large molecule space.

Scroll down for live Twitter updates from the event.

Related news

Related products

show more

Fill-Finish Biologics

Fill-Finish Biologics

Curia | 16-May-2022 | Technical / White Paper

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Related suppliers